OR WAIT null SECS
April 02, 2012
A recent survey examines the industry's views on the chief challenges and technologies in drug delivery and formulation development.
March 21, 2012
In our tablet coating process, we are losing up to 15% of our coating solution in each processing run. What can we do to prevent this problem in order to reduce waste and increase our cost efficiency?
March 02, 2012
The standardization of upstream and downstream bioprocessing is growing, but several kinks need to be ironed out.
Nanosupensions are among the ways formulation scientists seek to address the problem of solubility.
Genotoxic impurities and how to identify them and control for them have been a concern for several years in the pharmaceutical manufacturing industry. Pharmaceutical Technology spoke with Bo Shen, PhD, principal scientist at Amgen and chair of the AAPS Pharmaceutical Trace Impurities Focus Group, to gain insight on key challenges.
In Part II of a three-part article, the authors examine impurities from chiral molecules, polymorphic contaminants, and genotoxic impurities.
Wirelessly controlled microchips may offer an alternative to injection-based drug delivery
March 01, 2012
The author reviews significant changes to GMP for excipients in the forthcoming American National Standard, including a risk-based approach to excipient manufacture, why new requirements were proposed, and their potential impact to excipient manufacturers.
This article provides guidance for industry on how to comply with the pending American National Standard on excipient GMP, with a focus on risk assessment.
This article considers the different conditions to which the powder is subjected in the tableting process, and discusses which powder properties should be measured to accurately reflect likely powder behavior in the process.